Literature DB >> 19884645

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.

Debra Birnkrant1, Edward Cox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884645     DOI: 10.1056/NEJMp0910479

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  56 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

2.  Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.

Authors:  Yacine Abed; Andrés Pizzorno; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

3.  Successful management of fulminant influenza A subtype H1N1 myocarditis.

Authors:  Miguel Cobas; Lilian Abbo; Miguel Santos; Clara Baccini-Jauregui; Si Pham
Journal:  BMJ Case Rep       Date:  2010-09-17

4.  Chapter 5. Essential equipment, pharmaceuticals and supplies. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster.

Authors:  Charles L Sprung; Jozef Kesecioglu
Journal:  Intensive Care Med       Date:  2010-04       Impact factor: 17.440

5.  Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.

Authors:  Susu Duan; David A Boltz; Jiang Li; Christine M Oshansky; Henju Marjuki; Subrata Barman; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

6.  Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.

Authors:  Mitsutaka Kitano; Yasushi Itoh; Makoto Kodama; Hirohito Ishigaki; Misako Nakayama; Hideaki Ishida; Kaoru Baba; Takahiro Noda; Kenji Sato; Yoichiro Nihashi; Takushi Kanazu; Ryu Yoshida; Ryuzo Torii; Akihiko Sato; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191

7.  Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  Clin Infect Dis       Date:  2010-05-01       Impact factor: 9.079

Review 8.  Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Authors:  Roy F Chemaly; Dimpy P Shah; Michael J Boeckh
Journal:  Clin Infect Dis       Date:  2014-11-15       Impact factor: 9.079

Review 9.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

10.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.